Abstract
Streptozotocin is a natural product that selectively kills insulin-secreting beta cells, and is widely used to generate mouse models of diabetes or treat pancreatic tumors. Several studies suggest that streptozotocin toxicity stems from its N-nitrosourea moiety releasing nitric oxide and possessing DNA alkylating activity. However, it has also been proposed that streptozotocin induces apoptosis by inhibiting O-GlcNAcase, an enzyme that, together with O-GlcNAc transferase, is important for dynamic intracellular protein O-glycosylation. We have used galacto-streptozotocin to chemically dissect the link between O-GlcNAcase inhibition and apoptosis. Using X-ray crystallography, enzymology, and cell biological studies on an insulinoma cell line, we show that, whereas streptozotocin competitively inhibits O-GlcNAcase and induces apoptosis, its galacto-configured derivative no longer inhibits O-GlcNAcase, yet still induces apoptosis. This supports a general chemical poison mode of action for streptozotocin, suggesting the need for using more specific inhibitors to study protein O-GlcNAcylation.
| Original language | English |
|---|---|
| Pages (from-to) | 799-807 |
| Number of pages | 9 |
| Journal | Chemistry & Biology |
| Volume | 15 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 25 Aug 2008 |
Keywords
- beta-D-glucosaminidase
- N-acetylglucosamine
- Cytoplasmic proteins
- Structural insights
- Nitric oxide
- Inhibitor
- Glycosylation
- Transferase
- Alloxan
- Nuclear